Progestin-Only Oral Contraceptives Can Be Safely Used in Patients with Migraine with Aura
Yes, progestin-only oral contraceptives (POPs) are safe and appropriate for patients with migraine with aura, unlike combined hormonal contraceptives which are absolutely contraindicated in this population.
The Critical Distinction: Combined vs. Progestin-Only
The key issue is the estrogen component, not progestins. Combined hormonal contraceptives (CHCs) containing estrogen are contraindicated in women with migraine with aura regardless of any association with their menstrual cycle, owing to an associated increase in the risk of stroke 1. This is a Category 4 contraindication (unacceptable health risk) in the most recent U.S. Medical Eligibility Criteria 2.
However, progestin-only methods tell a completely different story.
Evidence Supporting Progestin-Only Pills in Migraine with Aura
The cardiovascular safety profile of progestin-only contraceptives is fundamentally different from combined methods:
A meta-analysis of six studies (3,091 cases and 11,385 controls) found the combined risk of stroke associated with progestin-based contraception was 0.96 (95% CI: 0.70-1.31) - essentially no increased risk 3
For myocardial infarction specifically, progestin-only pill use showed RR 0.98 (95% CI: 0.66-1.47) - again, no increased risk 4
The U.S. Medical Eligibility Criteria classifies POPs as Category 1 (no restriction) for women with migraine with aura 2
Clinical Algorithm for Contraceptive Selection in Migraine Patients
Step 1: Determine migraine subtype
- Migraine WITH aura (focal neurologic symptoms): POPs are safe; CHCs are absolutely contraindicated
- Migraine WITHOUT aura AND no other arterial risk factors: CHCs may be considered
- Migraine WITHOUT aura BUT with arterial risk factors (smoking, hypertension, age >35): CHCs contraindicated; use POPs
Step 2: Choose appropriate progestin-only method
- Progestin-only pills (norethindrone, drospirenone, desogestrel)
- Levonorgestrel IUD (also Category 1)
- Etonogestrel implant (Category 1)
- DMPA injection (Category 1)
Step 3: Counsel on stroke risk The absolute stroke risk remains elevated in migraine with aura patients regardless of contraceptive choice - the issue is that estrogen-containing methods amplify this baseline risk approximately 2-4 fold 5, 6. Progestin-only methods do not add to this risk 3.
Important Caveats
Watch for these pitfalls:
Accurate migraine classification is essential - aura is a specific focal neurologic symptom (visual disturbances, sensory changes, speech difficulties) that typically develops over 5-60 minutes 5. Don't confuse severe headache or photophobia with aura.
One case report exists of hemiplegic migraine potentially associated with etonogestrel implant 7, but this is an extremely rare event and hemiplegic migraine is a distinct, severe subtype. This single case does not change the overall safety profile established by large epidemiologic studies.
Current utilization patterns show many patients with migraine with aura still receive CHCs - a 2025 study found 15% of reproductive-age individuals with migraine with aura were using COCs post-diagnosis 8. This represents a significant quality gap in care.
The evidence base for progestin-only methods is less robust than for CHCs (fewer studies, smaller sample sizes) 9, but the available data consistently shows no increased stroke risk, which is the critical outcome for mortality and morbidity.
Practical Recommendation
For any woman with migraine with aura requiring contraception: prescribe progestin-only pills, implant, IUD, or DMPA 3, 2, 10, 11. The copper IUD is also an excellent non-hormonal option (Category 1). Never prescribe combined hormonal contraceptives (pills, patch, or ring) to these patients - this is an absolute contraindication based on stroke risk 1, 5, 2.
The guideline evidence is clear and consistent: progestin-only methods are safe; estrogen-containing methods are not.